Proceedings of the Frontiers of Retrovirology Conference 2016
2016 · Retrovirology · 37 citations
https://doi.org/10.1186/s12977-016-0294-5
C
Carsten Magnus
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
1.4K
Citations
20
h-index
25
i10-index
Carsten Magnus is an academic researcher from University of Zurich. The author has contributed to research in topics: HIV Research and Treatment & HIV/AIDS drug development and treatment & Immune Cell Function and Interaction. The author has an h-index of 20, co-authored 47 publications.
ORCID: 0000-0003-1125-2783Papers by this author
worksHeterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
2021 · Cell Reports Medicine · 27 citations
https://doi.org/10.1016/j.xcrm.2021.100209
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution
2015 · Virus Research · 15 citations
https://doi.org/10.1016/j.virusres.2015.10.009
The Open Hand Initiative: Facilitating the Use of Real‐World Evidence in Regulatory Submissions Through Collaboration and Transparency
2024 · Clinical Pharmacology & Therapeutics · 2 citations
https://doi.org/10.1002/cpt.3539
CD4<sup>low</sup> adapted envelopes show heightened sensitivity to inhibitors targeting the CD4bs, V3 loop, and CD4i epitopes, and patient plasma.
2017 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1006255.g009
Envelopes adapted to low levels of CD4 require a higher proportion of their available trimers to complete entry.
2017 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1006255.g010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat